Why this fundie doesn’t fear the Fed

In an article with AFR, James Miller of Firetrail Investments and 2022 Conference Manager goes into the US equity market correction and the stocks he’s looking to snatch up as well as steer clear of.

Why this fundie doesn’t fear the Fed

September 29, 2022
In an article with AFR, James Miller of Firetrail Investments and 2022 Conference Manager goes into the US equity market correction and the stocks he’s looking to snatch up as well as steer clear of.
Read Transcript

James Miller is a Portfolio Manager at Firetrail Investments for the Firetrail S3 Global Opportunities Fund. We spoke to him ahead of the fund listing on the ASX as an active ETF.

How are you reading the US equity market correction – does it represent a buying opportunity?

We think there are some great opportunities provided you can wear the short-term volatility. We don’t profess to be able to call the top or the bottom and don’t think anyone has an edge in calling the big macro turning points, but the medium-term outlook for specific stocks and sectors in the US is strong. The key is to be selective.

The irony for long-term holders of equities is the harder the Fed goes with fighting inflation, the better the situation is for businesses looking out five years.

I’d be more worried about the outlook for equity markets if central banks weren’t doing everything in their power to get inflation back down.

Which stocks are you looking at adding to, or snatching up, since valuations have fallen?

We are seeing a huge opportunity in memory chips, specifically what’s known as DRAM.

Micron Technology is one of the three companies that control over 90 per cent of this market. It’s a healthy oligopoly. Micron’s enterprise value is just over $US50 billion, but to replace its assets would cost over $US100 billion. It’s trading on 1 times book value, is free-cashflow positive, and is undertaking a share buyback.

Demand for DRAM has fallen in 2022 and all the main players have been quick to adjust their capital expenditure plans, and thus supply plans, for next year. Memory pricing is likely going to be tough for a couple of quarters, but the market being balanced is visible on the horizon. We expect the market to then begin to tighten up quickly, as the memory chip cycle is typically very fast, and supply takes 12-18 months to respond.

Which stocks/sectors could come under significant pressure?

We are steering clear of companies with poor balance sheets. For most, COVID-19 was a wake-up call to get their liquidity and debt under control when times are good. When conditions get tougher, as they are now, a strong balance sheet is vital. Highly geared companies are today facing higher costs of capital, and this raises the possibility of dilutive raisings at depressed share prices.

We are also wary of anything that is too exposed to the consumer. The rising cost of living in many developed markets is already beginning to have an impact on household balance sheets and there is a good chance that some companies find themselves trying to shift elevated levels of inventories in the coming year.

Why do you see European equities as an opportunity?

There are lots of hidden gems in European equities right now. Schneider Electric offers pragmatic solutions to energy efficiency. In Europe, as well as globally, you can see how difficult it is to increase the supply of energy in its various forms. Schneider operates on the demand side, ensuring that buildings and factories are minimising their use of electricity. Its switches, controls and systems aren’t always the fanciest, but they are trusted. We expect to see higher earnings to drive share price gains over the medium term.

What’s the most frustrating position in the portfolio?

HelloFresh’s share price performance has been frustrating in the short term, impacted by the tech and “COVID-19 winners” sell-off and concerns over the European macro backdrop, despite most of its revenue coming from the US. This has created the opportunity for us to increase our position.

From a fundamental view, the company is continuing to perform very well. Active customers are still growing, meals per customer are growing and the revenue per meal is growing. The gross margin has been expanding, it has €500 million cash on the balance sheet, and you only need to look two years forward to see a 10 per cent free cash flow yield.

The fund has underperformed its benchmark amid a volatile market for global equities. Why launch as an active ETF?

We’ve had experience launching funds in periods of heightened volatility. Firetrail launched our Australian small companies fund on 20th February 2020, which was the peak of the market before the sharp COVID-19 crash.

It was volatile – but also gave us some outstanding opportunities that we look for as a medium-term investor. Fast-forward to today, and that fund has outperformed the ASX Small Ordinaries benchmark.

We are seeing similar opportunities today in global equities. Whilst volatility has resulted in some short-term underperformance, we believe now is a great time for investors with a medium-term horizon to find global equity ideas that can outperform.

Favourite local bar or restaurant? What’s your go-to order?

North Sandwiches on Bridge Street in Sydney. The Hot & Blue is a must-try. Get there early to beat the crowd.

Any podcasts you’d recommend?

If you want to learn the details of how businesses evolve, then I can highly recommend How I Built This with Guy Raz. For those interested in technology companies, Acquired by Ben Gilbert and David Rosenthal is excellent. One warning though – some of these podcasts can be over four hours long, so settle in.

 

Disclaimer: This material has been prepared by AFR, published on 29 September 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

James Miller is a Portfolio Manager at Firetrail Investments for the Firetrail S3 Global Opportunities Fund. We spoke to him ahead of the fund listing on the ASX as an active ETF.

How are you reading the US equity market correction – does it represent a buying opportunity?

We think there are some great opportunities provided you can wear the short-term volatility. We don’t profess to be able to call the top or the bottom and don’t think anyone has an edge in calling the big macro turning points, but the medium-term outlook for specific stocks and sectors in the US is strong. The key is to be selective.

The irony for long-term holders of equities is the harder the Fed goes with fighting inflation, the better the situation is for businesses looking out five years.

I’d be more worried about the outlook for equity markets if central banks weren’t doing everything in their power to get inflation back down.

Which stocks are you looking at adding to, or snatching up, since valuations have fallen?

We are seeing a huge opportunity in memory chips, specifically what’s known as DRAM.

Micron Technology is one of the three companies that control over 90 per cent of this market. It’s a healthy oligopoly. Micron’s enterprise value is just over $US50 billion, but to replace its assets would cost over $US100 billion. It’s trading on 1 times book value, is free-cashflow positive, and is undertaking a share buyback.

Demand for DRAM has fallen in 2022 and all the main players have been quick to adjust their capital expenditure plans, and thus supply plans, for next year. Memory pricing is likely going to be tough for a couple of quarters, but the market being balanced is visible on the horizon. We expect the market to then begin to tighten up quickly, as the memory chip cycle is typically very fast, and supply takes 12-18 months to respond.

Which stocks/sectors could come under significant pressure?

We are steering clear of companies with poor balance sheets. For most, COVID-19 was a wake-up call to get their liquidity and debt under control when times are good. When conditions get tougher, as they are now, a strong balance sheet is vital. Highly geared companies are today facing higher costs of capital, and this raises the possibility of dilutive raisings at depressed share prices.

We are also wary of anything that is too exposed to the consumer. The rising cost of living in many developed markets is already beginning to have an impact on household balance sheets and there is a good chance that some companies find themselves trying to shift elevated levels of inventories in the coming year.

Why do you see European equities as an opportunity?

There are lots of hidden gems in European equities right now. Schneider Electric offers pragmatic solutions to energy efficiency. In Europe, as well as globally, you can see how difficult it is to increase the supply of energy in its various forms. Schneider operates on the demand side, ensuring that buildings and factories are minimising their use of electricity. Its switches, controls and systems aren’t always the fanciest, but they are trusted. We expect to see higher earnings to drive share price gains over the medium term.

What’s the most frustrating position in the portfolio?

HelloFresh’s share price performance has been frustrating in the short term, impacted by the tech and “COVID-19 winners” sell-off and concerns over the European macro backdrop, despite most of its revenue coming from the US. This has created the opportunity for us to increase our position.

From a fundamental view, the company is continuing to perform very well. Active customers are still growing, meals per customer are growing and the revenue per meal is growing. The gross margin has been expanding, it has €500 million cash on the balance sheet, and you only need to look two years forward to see a 10 per cent free cash flow yield.

The fund has underperformed its benchmark amid a volatile market for global equities. Why launch as an active ETF?

We’ve had experience launching funds in periods of heightened volatility. Firetrail launched our Australian small companies fund on 20th February 2020, which was the peak of the market before the sharp COVID-19 crash.

It was volatile – but also gave us some outstanding opportunities that we look for as a medium-term investor. Fast-forward to today, and that fund has outperformed the ASX Small Ordinaries benchmark.

We are seeing similar opportunities today in global equities. Whilst volatility has resulted in some short-term underperformance, we believe now is a great time for investors with a medium-term horizon to find global equity ideas that can outperform.

Favourite local bar or restaurant? What’s your go-to order?

North Sandwiches on Bridge Street in Sydney. The Hot & Blue is a must-try. Get there early to beat the crowd.

Any podcasts you’d recommend?

If you want to learn the details of how businesses evolve, then I can highly recommend How I Built This with Guy Raz. For those interested in technology companies, Acquired by Ben Gilbert and David Rosenthal is excellent. One warning though – some of these podcasts can be over four hours long, so settle in.

 

Disclaimer: This material has been prepared by AFR, published on 29 September 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

Disclaimer: This material has been prepared by Australian Financial Review, published on Sep 29, 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/BloombergMike Novogratz, CEO of Galaxy Digital. Photo: Jutharat Pinyodoonyachet/Bloomberg
November 9, 2024

Galaxy Digital CEO Mike Novogratz believes bitcoin will hit $US100k

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for cryptocurrency, says US billionaire Mike Novogratz.

Read More
Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍
November 6, 2024

Why this New York hedge fund manager sees opportunity in European stocks

Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.

Read More
Vihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie Douvis
November 5, 2024

Antipodes’ Ross says short-term wealth hinges on US election

The portfolio manager says defensive stocks pose a bigger risk than the magnificent seven for investors that are overexposed to the American sharemarket.

Read More
Antipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John Feder
November 5, 2024

Concentration risk key for investors: Antipodes Partners’ Vihari Ross

The concentration risk in global stock indexes that has built up during the strong rise over the past year must now be a key consideration for global investors, according to Vihari Ross.

Read More
JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.
November 5, 2024

The fundie betting big on China – with help from AI

Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.

Read More
Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.
October 29, 2024

Why this fundie wants you to ‘wince’ at his stock picks

When fund managers come to pitch their favourite stock at the annual Sohn Hearts & Minds conference, there are two ways they can go: they can play it safe, or they can take a risk and shock the room.

Read More
October 27, 2024

IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.

Read More
October 22, 2024

Meet the 2024 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share eleven new managers for 2024.

Read More
October 21, 2024

Chris Kourtis is on a winning streak. Here’s his next ASX pick

Chris Kourtis of Ellerston Capital thinks he’s found another winner and thinks it’s the last chance to have a bite at the cherry before the strategy plays out.

Read More
Ellerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta Campion
October 21, 2024

Why Ellerston Capital’s Chris Kourtis plans to back a ‘hated’ stock

Chris Kourtis of Ellerston Capital plans to tip one of the “most hated” stocks in Australia when he presents at the 2024 Sohn Hearts & Minds Conference.

Read More
 ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion
October 14, 2024

Alex Pollak champions rewards of disruptive investment

Alex Pollak’s funds management company Loftus Peak rode the Nvidia wave and he is now looking at more opportunities in disruptive industry stocks.

Read More
October 8, 2024

Sumit Gautam - Why AI won't deliver in 2025 | Scalar Gauge

Sumit Gautam is the Founder of Scalar Gauge and speaks with Equity Mates ahead of his appearance at the Sohn Hearts & Minds conference.

Read More
September 30, 2024

Missed out on Nvidia and Ozempic? This fundie says it’s never too late

Northcape Capital’s Fleur Wright is still kicking herself for not owning market darlings Nvidia and Novo Nordisk, the maker of the weight loss wonder drug Ozempic, before shares of those companies rocketed in 2023.

Read More
September 23, 2024

Scalar Gauge Fund founder Sumit Gautam cautious about over-hyped AI

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype.

Read More
September 9, 2024

The Wellcome Trust’s Nick Moakes made a 100-year bet. It’s paying off

Chief Investment Officer, Nick Moakes raised almost $3 billion at ultra-low rates. Sometimes the long view can be the most profitable.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.